Navigation Links
Quaker Oats and Share Our Strength Announce New Movement to Fight Childhood Hunger
Date:3/9/2009

Philanthropist and Renowned Chef Art Smith Creates Oat-Inspired Menu to Power Americans to Do Good

NEW YORK, March 9 /PRNewswire/ -- In Times Square today, Quaker announces the launch of the Go Project, a new social purpose movement powered by Quaker and the human energy of Americans across the country. Quaker, which energizes people's lives every day with the wholesome goodness of whole-grain oats, is now encouraging Americans to use that energy to fuel it forward for others through donations, grants and volunteer opportunities.

More than 36 million Americans -- including 12.4 million children -- are at risk of hunger. To help combat childhood hunger, the Quaker Go Project is empowering consumers to activate hunger-related volunteerism projects in their own communities by applying for a Go Grant. Consumers can visit www.quakeroats.com/gohumansgo between now and July 31, 2009 and share their ideas for a hunger-related project for the opportunity to receive a $500 grant.*

"For more than 130 years, Quaker Oats has been one of the most trusted and valued brands in America for delivering quality whole-grain oat goodness across our portfolio of products," said Mark Schiller, president of Quaker Oats. "Through the Quaker Go Project, and our ongoing efforts to fight childhood hunger, we can give people the fuel to live their lives to the fullest and to do good in their communities."

In partnership with American families, Quaker will donate up to 1 million servings of products made with whole-grain oats to Share Our Strength, the nation's leading organization working to end childhood hunger in America. Each time a consumer enters a UPC code from any package of Quaker Oats, Quaker Instant Oatmeal, Quaker Oatmeal Squares, Quaker Life cereal or Quaker Chewy granola bars at

SOURCE Quaker Oats
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Quaker Introduces Simple Harvest(TM) All Natural Multigrain Chewy Granola Bars That Taste Simply Delicious
2. Quaker(R) Life(R) Cereal Partners with Actress and Mom Holly Robinson Peete to Inspire Moms to Make Their Best Days Happen
3. King of Talk Celebrates Milestone With Quaker, The King of Hearts
4. Roche Increases Offer Price for Genentech Shares to US$ 93.00 per Share and Extends Offer
5. Leading Proxy Advisory Firm RiskMetrics Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Proposals by Dissident Joffe Group
6. NACDS Commends Obama's Shared Commitment on Accessible, Quality and Affordable Healthcare
7. Tyco to Host 2009 Annual General Meeting and Special General Meeting of Shareholders
8. Sodexo Shares Top Breakfast Benefits for Students
9. Rochester Medical Renews Share Repurchase Activity
10. A Broad-Spectrum Antibiotic with Activity Against MRSA and Pseudomonas Aeruginosa Would Earn a Higher Patient Share in the U.S. than in Europe for the Treatment of Hospital-Acquired Pneumonia
11. University of the Rockies Faculty and Students Travel to China to Share Western Philosophy
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine Technology:Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 2Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 3Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 4Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 5Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 2Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 3Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 4Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 5Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 6